These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 17970072

  • 21. Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.
    Xia Q, Sung J, Chowdhury W, Chen CL, Höti N, Shabbeer S, Carducci M, Rodriguez R.
    Cancer Res; 2006 Jul 15; 66(14):7237-44. PubMed ID: 16849572
    [Abstract] [Full Text] [Related]

  • 22. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
    Yu S, Wang X, Ng CF, Chen S, Chan FL.
    Cancer Res; 2007 May 15; 67(10):4904-14. PubMed ID: 17510420
    [Abstract] [Full Text] [Related]

  • 23. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
    Archer SY, Johnson J, Kim HJ, Ma Q, Mou H, Daesety V, Meng S, Hodin RA.
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct 15; 289(4):G696-703. PubMed ID: 16160080
    [Abstract] [Full Text] [Related]

  • 24. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
    Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, Sheng S, Yan B, Reddy GP, Dou QP.
    Cancer Res; 2007 Feb 15; 67(4):1636-44. PubMed ID: 17308104
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.
    Kim IY, Seong DH, Kim BC, Lee DK, Remaley AT, Leach F, Morton RA, Kim SJ.
    Cancer Res; 2002 Jul 01; 62(13):3649-53. PubMed ID: 12097269
    [Abstract] [Full Text] [Related]

  • 31. Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers.
    Ren G, Zhang G, Dong Z, Liu Z, Li L, Feng Y, Su D, Zhang Y, Huang B, Lu J.
    Int J Biochem Cell Biol; 2009 May 01; 41(5):1094-101. PubMed ID: 19013255
    [Abstract] [Full Text] [Related]

  • 32. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus.
    Jia L, Coetzee GA.
    Cancer Res; 2005 Sep 01; 65(17):8003-8. PubMed ID: 16140973
    [Abstract] [Full Text] [Related]

  • 33. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.
    Zaidman BZ, Wasser SP, Nevo E, Mahajna J.
    Int J Oncol; 2007 Oct 01; 31(4):959-67. PubMed ID: 17786330
    [Abstract] [Full Text] [Related]

  • 34. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells.
    Im JY, Park H, Kang KW, Choi WS, Kim HS.
    Chem Biol Interact; 2008 Apr 15; 172(3):235-44. PubMed ID: 18313654
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
    Hsieh CL, Cai C, Giwa A, Bivins A, Chen SY, Sabry D, Govardhan K, Shemshedini L.
    J Mol Endocrinol; 2008 Jul 15; 41(1):13-23. PubMed ID: 18469090
    [Abstract] [Full Text] [Related]

  • 39. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
    Valentini A, Biancolella M, Amati F, Gravina P, Miano R, Chillemi G, Farcomeni A, Bueno S, Vespasiani G, Desideri A, Federici G, Novelli G, Bernardini S.
    Drug Metab Dispos; 2007 Jun 15; 35(6):968-72. PubMed ID: 17371798
    [Abstract] [Full Text] [Related]

  • 40. [Clinical role of cell cycle regulators in androgen-dependent cancer cell growth].
    Hashimoto Y, Akita H, Iizuka A, Hibino M, Kohri K.
    Hinyokika Kiyo; 2000 Oct 15; 46(10):763-7. PubMed ID: 11215207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.